Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,188.34
(
-1.10%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 92535

Monday, 04/19/2010 6:23:57 PM

Monday, April 19, 2010 6:23:57 PM

Post# of 257580
BMY Presents Phase-2a Data on NS5A Inhibitor at EASL

http://www.bms.com/research/investigational/hepatitis/Pages/BMS790052_easl.aspx

BMY did not issue a PR for this BMS-790052 presentation, but the info was posted on BMY’s new webpage for real-time pipeline updates (#msg-49176165). Due to the formatting, this info is difficult to post and is best read by chasing the link above (it will not expire :- )).

The abstract for this study was posted in #msg-47876219; an updated version of the abstract with a data table is at http://www.kenes.com/easl2010/Orals/297.htm .


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today